312 results
Page 3 of 16
8-K
EX-99.1
eol7wh7 7uxvo
3 Aug 22
Cassava Sciences Reports Second Quarter Financial Results for 2022, Mid-year Corporate Update and Interim Analysis of Open-label Study
9:25am
424B5
0rb k353bym
29 Jul 22
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.1
nzrf 8qy83w
5 May 22
Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program
9:04am
8-K
EX-99.1
zvbsfhfu2qp
28 Feb 22
Cassava Sciences Reports Full-year 2021 Financial Results and Operating Updates
12:00am
8-K
EX-99.1
d1qugq
10 Nov 21
Cassava Sciences Reports Third Quarter 2021 Financial Results
9:10am
8-K
EX-99.1
4ylkxtp
3 Aug 21
Regulation FD Disclosure
4:36pm
8-K
EX-99.3
iczefsapijxb
3 Aug 21
Regulation FD Disclosure
4:36pm
8-K
EX-99.2
uo1 6b2xcel8964157rk
3 Aug 21
Regulation FD Disclosure
4:36pm
8-K
EX-99.1
e8qzkhi6 xli
3 Aug 21
Cassava Sciences Reports Second Quarter 2021 Financial Results
8:45am
8-K
EX-99.1
68t700etmd1gpgxf2sii
21 Jun 21
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-99.1
bukuyb6eeng7hazcn yt
14 Jun 21
Cassava Sciences Announces the Appointment of
4:14pm